Arterial Stents - Global Strategic Business Report

The global market for Arterial Stents was valued at USD 15.7 Billion in 2024 and is projected to reach USD 25.2 Billion by 2030, growing at a CAGR of 8.3% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Arterial Stents Market - Key Trends & Drivers Summarized

Why Are Arterial Stents Crucial for Managing Cardiovascular Diseases?

Arterial stents have become an essential medical device in the treatment of cardiovascular diseases, particularly in patients suffering from coronary artery disease (CAD) or peripheral artery disease (PAD). These small, tube-like devices are used to open up blocked or narrowed arteries, ensuring proper blood flow to the heart and other critical organs. With cardiovascular diseases remaining the leading cause of death worldwide, arterial stents play a vital role in reducing complications such as heart attacks, strokes, and limb ischemia. The growing incidence of lifestyle-related health conditions, including obesity, diabetes, and hypertension, has further driven the demand for arterial stents, making them a key component of modern cardiovascular care.

How Are Technological Advances Revolutionizing Arterial Stent Design?

The development of drug-eluting stents (DES) and bioresorbable stents represents a significant technological advancement in the arterial stent market. Drug-eluting stents release medications over time to prevent restenosis, the re-narrowing of the artery, which has improved patient outcomes by reducing the need for repeat interventions. Bioresorbable stents, which gradually dissolve after fulfilling their purpose, offer a promising solution for reducing long-term complications associated with traditional metal stents. Furthermore, advances in imaging technology, such as optical coherence tomography (OCT) and intravascular ultrasound (IVUS), have improved the precision with which stents are deployed, enhancing the success of stenting procedures. These innovations are transforming the stent market by offering safer, more effective solutions for managing complex cardiovascular conditions.

What Regulatory Standards Are Shaping the Arterial Stents Market?

Regulatory standards play a crucial role in the arterial stents market, as the safety and efficacy of these medical devices must be carefully evaluated before they can be used in patients. Agencies such as the FDA and European Medicines Agency (EMA) require that stents undergo rigorous clinical testing to ensure they meet stringent quality and safety standards. This includes demonstrating the stent's ability to maintain arterial patency without causing adverse effects such as blood clotting or inflammation. Post-market surveillance is also essential, as it allows regulatory bodies to monitor long-term patient outcomes and identify any emerging risks associated with new stent technologies. Compliance with these standards is vital for manufacturers to gain approval and build trust with healthcare providers and patients.

What Factors Are Driving the Growth of the Arterial Stents Market?

The growth in the arterial stents market is driven by several factors, including the rising prevalence of cardiovascular diseases, technological advancements in stent design, and the increasing demand for minimally invasive procedures. The global burden of heart disease and stroke is prompting greater demand for stent-based interventions, particularly as healthcare systems shift toward preventive care and early diagnosis. Technological innovations such as drug-eluting and bioresorbable stents are improving patient outcomes, leading to increased adoption in both developed and emerging markets. The growing preference for minimally invasive procedures, which offer quicker recovery times and reduced complications, is further boosting the use of arterial stents. Additionally, the expansion of healthcare infrastructure in developing countries is opening new opportunities for market growth as access to advanced cardiovascular care increases.

Report Scope

The report analyzes the Arterial Stents market, presented in terms of market value (USD Thousand). The analysis covers the key segments and geographic regions outlined below.

Segments

Application (Coronary Artery, Carotid Artery, Iliac Artery, Other Applications); Product (Coronary Stents, Peripheral Stents).

Geographic Regions/Countries

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Coronary Stents segment, which is expected to reach $12.8 Billion by 2030 with a CAGR of a 8.1%. The Peripheral Stents segment is also set to grow at 8.4% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $4 Billion in 2024, and China, forecasted to grow at an impressive 12% CAGR to reach $6.3 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in USD from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of major players such as Abbott Laboratories, B. Braun Melsungen AG, BARD, A Becton, Dickinson Company, Biotronik SE & Co. KG, Boston Scientific Corporation and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Arterial Stents Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Arterial Stents Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Arterial Stents Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Some of the 46 major companies featured in this Arterial Stents market report include:

• Abbott Laboratories
• B. Braun Melsungen AG
• BARD, A Becton, Dickinson Company
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cook Group, Inc.
• Medtronic PLC
• MicroPort Scientific Corporation
• Stentys SA
• Terumo Corporation